Barely Significant
← all excerpts

Integrated ICD-based subtyping and prognostic model reveal KCNN4 as a novel therapeutic target in NSCLC.

Discov Oncol · 2026 · PMC13038718 · PMID 41741906

Europe PMCDOI
1
hedged sentence
0.0002
closest p · 0.0× alpha
0.0002
boldest claim

The sentences

highly significantP = 0.0002actually significant
By day 3, the deficit was large and highly significant (sh-NC 2.21 ± 0.07 vs. sh-KCNN4 1.60 ± 0.13; mean difference 0.60 [95% CI 0.40–0.81]; adjusted P = 0.0002).These findings demonstrate a time-dependent and quantitatively large suppression of PC-9 proliferation following KCNN4 knockdown.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.